Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR)

Delayed Data
As of 3:59pm ET
 -0.21 / -0.24%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 12 analysts offering 12-month price forecasts for Arrowhead Pharmaceuticals Inc have a median target of 94.00, with a high estimate of 106.00 and a low estimate of 44.00. The median estimate represents a +6.21% increase from the last price of 88.50.

Analyst Recommendations

The current consensus among 12 polled investment analysts is to Buy stock in Arrowhead Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 46.43%
Growthannually 39.07%


Growthquarterly 31.85%
Growthannually 94.82%
Key to the earnings and sales forecast charts.